L-carnitine and Metformin in Obese PCOS Women.
Launched by ZAGAZIG UNIVERSITY · Apr 6, 2017
Trial Information
Current as of June 13, 2025
Completed
Keywords
ClinConnect Summary
the trial aims to compare L-carnitine and plus metformin in clomiphene-resistant obese PCOS women with placebo to state the reproductive and metabolic effects in form of pregnancy and insulin resistance parameters and lipid metabolism.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • pco
- • obese
- • ifertile
- Exclusion Criteria:
- • no medical disorders
- • no hormonal treatment in the previous 3 months
About Zagazig University
Zagazig University, a prominent educational and research institution located in Egypt, plays a pivotal role in advancing medical knowledge and promoting health innovations through its clinical trials. With a commitment to excellence in research, the university leverages its diverse expertise and state-of-the-art facilities to conduct rigorous clinical studies that aim to improve patient care and outcomes. By fostering collaboration among multidisciplinary teams, Zagazig University contributes significantly to the global medical community, ensuring that its clinical trials adhere to the highest ethical standards and regulatory requirements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zagazig, , Egypt
Patients applied
Trial Officials
ibrahim A el sharkwy, MD
Principal Investigator
FACULTY OF MEDICINE ,ZAGAZIG UNIVERSITY
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials